Suppr超能文献

胰岛素样生长因子1受体mRNA在人子宫肌层和平滑肌瘤中的表达及自身磷酸化

Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma.

作者信息

Martin Chaves E B, Brum I S, Stoll J, Capp E, Corleta H v E

机构信息

Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

出版信息

Gynecol Obstet Invest. 2004;57(4):210-3. doi: 10.1159/000076690. Epub 2004 Feb 9.

Abstract

Uterine leiomyomas are the most common tumors of the genital tract. Growth factors seem to be implicated in the development of leiomyoma. The aim of this study was to determine insulin-like growth factor 1 receptor (IGF-1-R) mRNA levels and IGF-1-R tyrosine kinase activity in normal myometrium and leiomyoma. Plasma membranes of myometrium and leiomyoma of 14 women subjected to hysterectomy were prepared, and samples were incubated in the absence or presence of recombinant human IGF-1 to assess the tyrosine kinase activity (Western blot). Reverse-transcriptase polymerase chain reaction with specific primers for IGF-1-R was used to determine IGF-1-R mRNA levels. IGF-1-R mRNA levels in myometrium (0.8216 +/- 0.096) and in leiomyoma (0.7905 +/- 0.136) were not statistically significantly different (p = 0.648). The degree of IGF-1-R autophosphorylation stimulated by recombinant IGF-1 was not different in myometrium (1.020 +/- 0.120) and leiomyoma (1.620 +/- 0.656) either (p = 0.075). There was no difference in IGF-1-R expression and IGF-1-R autophosphorylation between normal myometrium and leiomyoma.

摘要

子宫平滑肌瘤是生殖道最常见的肿瘤。生长因子似乎与平滑肌瘤的发生有关。本研究的目的是测定正常子宫肌层和平滑肌瘤中胰岛素样生长因子1受体(IGF-1-R)mRNA水平及IGF-1-R酪氨酸激酶活性。制备了14例行子宫切除术妇女的子宫肌层和平滑肌瘤的质膜,样本在不存在或存在重组人IGF-1的情况下孵育以评估酪氨酸激酶活性(蛋白质免疫印迹法)。使用针对IGF-1-R的特异性引物进行逆转录聚合酶链反应来测定IGF-1-R mRNA水平。子宫肌层(0.8216±0.096)和平滑肌瘤(0.7905±0.136)中的IGF-1-R mRNA水平无统计学显著差异(p = 0.648)。重组IGF-1刺激的IGF-1-R自身磷酸化程度在子宫肌层(1.020±0.120)和平滑肌瘤(1.620±0.656)中也无差异(p = 0.075)。正常子宫肌层和平滑肌瘤之间的IGF-1-R表达及IGF-1-R自身磷酸化无差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验